A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.

de Winter RJ, Katagiri Y, Asano T, Milewski KP, Lurz P, Buszman P, Jessurun GAJ, Koch KT, Troquay RPT, Hamer BJB, Ophuis TO, Wöhrle J, Wyderka R, Cayla G, Hofma SH, Levesque S, Żurakowski A, Fischer D, Kośmider M, Goube P, Arkenbout EK, Noutsias M, Ferrari MW, Onuma Y, Wijns W, Serruys PW

Open source

DOI
10.1016/s0140-6736(17)33103-3
Published
2018 Feb 3
Container
Lancet (London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-17-33103-3,
  title = {A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.},
  author = {de Winter RJ and Katagiri Y and Asano T and Milewski KP and Lurz P and Buszman P and Jessurun GAJ and Koch KT and Troquay RPT and Hamer BJB and Ophuis TO and Wöhrle J and Wyderka R and Cayla G and Hofma SH and Levesque S and Żurakowski A and Fischer D and Kośmider M and Goube P and Arkenbout EK and Noutsias M and Ferrari MW and Onuma Y and Wijns W and Serruys PW},
  year = {2018},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(17)33103-3},
  url = {https://doi.org/10.1016/s0140-6736(17)33103-3}
}

RIS

TY  - JOUR
TI  - A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.
AU  - de Winter RJ
AU  - Katagiri Y
AU  - Asano T
AU  - Milewski KP
AU  - Lurz P
AU  - Buszman P
AU  - Jessurun GAJ
AU  - Koch KT
AU  - Troquay RPT
AU  - Hamer BJB
AU  - Ophuis TO
AU  - Wöhrle J
AU  - Wyderka R
AU  - Cayla G
AU  - Hofma SH
AU  - Levesque S
AU  - Żurakowski A
AU  - Fischer D
AU  - Kośmider M
AU  - Goube P
AU  - Arkenbout EK
AU  - Noutsias M
AU  - Ferrari MW
AU  - Onuma Y
AU  - Wijns W
AU  - Serruys PW
PY  - 2018
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(17)33103-3
UR  - https://doi.org/10.1016/s0140-6736(17)33103-3
ER  - 

APA

RJ, D. W., Y, K., T, A., KP, M., P, L., P, B., GAJ, J., KT, K., RPT, T., BJB, H., TO, O., J, W., R, W., G, C., SH, H., S, L., A, Ż., D, F., M, K., P, G., EK, A., M, N., MW, F., Y, O., W, W., & PW, S. (2018). A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(17)33103-3

Source records